REZOLUTE, INC. Form CT ORDER: SEC order granting confidential treatment
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2019-03-18: Form CT ORDER; Description SEC order granting confidential treatment; Document filename1.pdf.
- 2018-06-25: Form CT ORDER; Description SEC order granting confidential treatment; Document filename1.pdf.
- 2018-03-15: Form CT ORDER; Description SEC order granting confidential treatment; Document filename1.pdf.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2019-03-18 | CT ORDER | SEC order granting confidential treatment | filename1.pdf | |
| 2018-06-25 | CT ORDER | SEC order granting confidential treatment | filename1.pdf | |
| 2018-03-15 | CT ORDER | SEC order granting confidential treatment | filename1.pdf |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |